Viatris Announces 2026 Dividend Policy

Sixth straight year of dividends for the global healthcare company

Feb. 26, 2026 at 11:55am

Got story updates? Submit your updates here. ›

Viatris Inc. (Nasdaq: VTRS) announced that its Board of Directors has approved a 2026 dividend policy of $0.48 per share and declared a quarterly dividend of $0.12 per share, payable on March 18, 2026 to shareholders of record as of March 9, 2026. This marks the sixth consecutive year the company has paid a dividend.

Why it matters

Viatris' consistent dividend payouts demonstrate the company's financial stability and commitment to returning value to its shareholders, even as it navigates the evolving healthcare landscape. This announcement is likely to be well-received by investors and could help bolster confidence in the company's long-term prospects.

The details

The $0.48 per share annual dividend policy and $0.12 quarterly payout are in line with Viatris' previous dividend practices. The company, formed in 2020 through the merger of Pfizer's Upjohn division and Mylan, has now maintained a steady dividend for six straight years, providing a reliable income stream for shareholders.

  • Viatris' Board of Directors approved the 2026 dividend policy on February 23, 2026.
  • The quarterly dividend of $0.12 per share is payable on March 18, 2026 to shareholders of record as of March 9, 2026.

The players

Viatris Inc.

A global healthcare company that combines generics and branded medicines to address healthcare needs worldwide. Viatris was formed in 2020 through the merger of Pfizer's Upjohn division and Mylan.

Got photos? Submit your photos here. ›

What’s next

Viatris' shareholders will receive the $0.12 per share quarterly dividend payment on March 18, 2026.

The takeaway

Viatris' consistent dividend payouts over the past six years demonstrate the company's financial strength and commitment to shareholder value, even as it navigates the evolving global healthcare landscape.